Management of cases testing positive for gonococcal infection in a community-based chlamydia screening programme

Sexually Transmitted Infections

Volumn 86, Issue 6, 2010, Pages 474-477

  Downing, Jennifer ^a   Cook, Penny A ^a   Madden, Hannah C E ^a   Phillips Howard, Penelope A ^a   Higgins, Stephen P ^b   Bellis, Mark A ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CHLAMYDIA; COMMUNITY CARE; CONTROLLED STUDY; FEMALE; GONORRHEA; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; PATIENT REFERRAL; PRIORITY JOURNAL; SCREENING TEST; UNITED KINGDOM;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; COMMUNITY HEALTH SERVICES; ENGLAND; FEMALE; GONORRHEA; HUMANS; MALE; MASS SCREENING; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 78449232164     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2010.043240     Document Type: Article

References (17)

1. Health Protection Agency. Selected STI diagnoses made at GUM clinics in the UK 1998-2007 2008. http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/ 1215589014186 (accessed 29 Mar 2009).
2. European Surveillance of Sexually Transmitted Infections. Sexually Transmitted Infections in Europe; annual report No. 3. London: Health Protection Agency, 2008.
3. European Centre for Disease Prevention and Control. ECDC guidance: Chlamydia control in Europe. ECDC 2009.
4. National Chlamydia Screening Programme, NCSP Newsletter, 2008. issue 52.
5. Creighton S, Tenant-Flowers M, Taylor CB, et al. Co-infection with Gonorrhoea and Chlamydia: How much is there and what does it mean? Int J STD AIDS 2003;14:109-13.
6. Golden MR, Hughes JP, Cles LE, et al. Positive predictive value of Gen-Probe APTIMA Combo 2 testing for Neisseria gonorrhoeae in a population of women with low prevalence of N. gonorrhoeae infection. Clin Infect Dis 2004;39:1387-90.
7. Mahto M, Zia S, Ritchie D, et al. Diagnosis, management and prevalence estimation of gonorrhoea: influences of Aptima Combo 2 assay with alternative target confirmation. Int J STD AIDS 2009;20:315-19.
8. O'Mahoney C, Reeve-Fowkes A, Worthen E, et al. Three years of using Aptima Combo 2 (AC2) transcription-mediated amplification for gonorrhoea in a district hospital genitourinary medicine clinic show it to be superior to culture and has a specificity of almost 100%. Int J STD AIDS 2008;19:67-9.
9. Lavelle S, Jones KE, Mallinson H, et al. Finding, confirming, and managing gonorrhoea in a population screened for Chlamydia using the Gen-Probe Aptima Combo2 Assay. Sex Transm Infect 2006;82:221-4.
10. Lavelle S. An Evaluation of Concomitant Screening for Neisseria Gonorrhoea (NG) Within a Chlamydia Screening Programme (CSP) Using the Gen-Probe APTIMA Combo2 Assay (dissertation): Centre for Public Health, Liverpool John Moores University, 2008.
11. British Association for Sexual Health and HIV. National Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults 2005. BASSH 2005.
12. Health Protection Agency and British Association for Sexual Health and HIV. Guidance for Gonorrhoea testing in England and Wales. HPA 2010.
13. Janier M, Lassau F, Cassin I, et al. Pharyngeal gonorrhoea: the forgotten reservoir. Sex Transm Infect 2003;79:345.
14. McDonagh P, Ryder N, McNulty AM, et al. Neisseria gonorrhoeae infection in urban Sydney women: prevalence and predictors. Sex Health 2009;6:241-4.
15. Downing J, Madden HCE, Phillips-Howard PA, et al. Evaluation of the Greater Manchester R U Clear? Chlamydia and Gonorrhoea screening programme: Centre for Public Health, Liverpool John Moores University, 2009.
16. Fitzgerald M, Bedford C. National standards for the management of gonorrhoea. Int J STD AIDS 1996;7:298-300.
17. Gopal Rao G, Bacon L, Evans J, et al. Can culture confirmation of gonococcal infection be improved in female subjects found to be positive by nucleic acid amplification tests in community clinics. Sex Transm Infect 2009;85:531-3.